AG
NAGE

Advisor Group’s Niagen Bioscience NAGE Stock Holding History

Advisor Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Buy
+270
New +$960 ﹤0.01% 5222

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
MFCM
Mercator Fund (Cayman Master) New York $125M AUM
SA
Sycale Advisors New York $326M AUM 6.53% 1-Year Est. Return

Advisor Group's NAGE Position: Q4 2019 in Review

Advisor Group opened a new position in Niagen Bioscience (NAGE) in Q4 2019: 270 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #5222 among its holdings.

65 funds tracked by Wall St. Rank hold NAGE as of Q4 2019.

  • Advisor Group held 270 shares of Niagen Bioscience worth $1K as of Q4 2019.
  • Niagen Bioscience was a new Advisor Group position in Q4 2019.
  • Niagen Bioscience made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5222 holding.
  • 65 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.